# OnCo record paper-mondaca-erbb2-gallbladder-us-chile-jco-go-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mondaca-erbb2-gallbladder-us-chile-jco-go-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mondaca-erbb2-gallbladder-us-chile-jco-go-2024" ;
  schema:name "Clinical and genomic characterization of ERBB2-altered gallbladder cancer: exploring differences between an American and a Chilean cohort"@en ;
  schema:description "In 260 gallbladder cancer patients from New York and Santiago, HER2 gene changes were found in about one in seven at both centres, split between extra copies and point mutations, and patients with them lived longer."@en ;
  schema:url <https://onco.cc/key-papers/paper-mondaca-erbb2-gallbladder-us-chile-jco-go-2024/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/go.24.00090>, <https://pubmed.ncbi.nlm.nih.gov/39388662/> ;
  schema:sameAs <https://doi.org/10.1200/go.24.00090> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Mondaca S, Walch H, Sepulveda S, et al." ;
  onco:cancers <https://onco.cc/cancers/gallbladder/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/zanidatamab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:people <https://onco.cc/people/ghassan-abou-alfa/> .